Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surgical menopause and cardiovascular risks.

Rogerio A Lobo1

  • 1Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY 10032, USA. ral35@columbia.edu

Menopause (New York, N.Y.)
|May 4, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Association between central adiposity and cognitive domain function in recently postmenopausal women: an analysis from the KEEPS-Cog substudy of the Kronos Early Estrogen Preventive Study.

Menopause (New York, N.Y.)·2025
Same author

Increased Serum AMH in a Subgroup of Women with Idiopathic Hyperandrogenism: Do These Women Have PCOS?

Biomedicines·2025
Same author

Long-term effects of 4 years of menopausal hormone therapy on white matter integrity.

Menopause (New York, N.Y.)·2025
Same author

Associations of blood pressure with white matter hyperintensities later in life; influence of short-term menopausal hormone therapy.

Menopause (New York, N.Y.)·2024
Same author

Long-term cognitive effects of menopausal hormone therapy: Findings from the KEEPS Continuation Study.

PLoS medicine·2024
Same journal

Combined adductor pollicis muscle thickness and handgrip strength as predictive indicators for risk stratification of low muscle mass and low bone mass in adult women.

Menopause (New York, N.Y.)·2026
Same journal

Novel and traditional anthropometric measures of obesity association with dynapenia in postmenopausal women.

Menopause (New York, N.Y.)·2026
Same journal

Regulatory awareness, counseling priorities, and treatment choices in menopausal hormone therapy: a cross-sectional survey of obstetricians and gynecologists.

Menopause (New York, N.Y.)·2026
Same journal

Menopause Step-by-Step: must-know studies.

Menopause (New York, N.Y.)·2026
Same journal

Processed foods in the context of a vegan diet, and changes in body weight and severe hot flashes in postmenopausal women: a secondary analysis of a randomized clinical trial.

Menopause (New York, N.Y.)·2026
Same journal

Female and male factors associated with female sexual function in couples aged 50-70 years: a cross-sectional study.

Menopause (New York, N.Y.)·2026
See all related articles

Surgical menopause before age 50 significantly increases cardiovascular disease (CVD) risk, particularly coronary heart disease. Estrogen therapy may offer protection, while hysterectomy alone does not increase CVD risk.

Area of Science:

  • Gynecology
  • Cardiology
  • Reproductive Medicine

Background:

  • Surgical menopause, induced by bilateral oophorectomy, is a critical factor influencing women's cardiovascular health.
  • Early menopause, occurring before age 50, is linked to heightened risks of cardiovascular disease (CVD).

Purpose of the Study:

  • To synthesize existing literature on the impact of surgically induced menopause on cardiovascular disease (CVD) development.
  • To differentiate the CVD risks associated with various surgical procedures, including oophorectomy and hysterectomy.

Main Methods:

  • Systematic literature review of studies investigating surgical menopause and cardiovascular outcomes.
  • Analysis of data differentiating between pre-menopausal and peri-menopausal bilateral oophorectomy.
  • Evaluation of the role of estrogen therapy and hysterectomy in cardiovascular risk.

Related Experiment Videos

Main Results:

  • Bilateral oophorectomy before natural menopause significantly elevates CVD risk.
  • Oophorectomy around the time of menopause shows minimal to no increased CVD risk.
  • Estrogen therapy may provide a protective effect against CVD in this context.
  • The primary CVD risk identified is coronary heart disease, not cerebrovascular disease.

Conclusions:

  • Early menopause, whether spontaneous or surgical, is associated with increased mortality.
  • Hysterectomy without bilateral oophorectomy does not appear to elevate CVD risk.
  • Understanding these risks is crucial for managing women's long-term cardiovascular health post-surgery.